阿霉素全球市场 2023-2027

报告预测，阿霉素的市场规模在2022-2027年期间将增长至4.6997亿美元，预测期内復合年增长率为6.07%。

该报告提供了总体分析、市场规模和预测、趋势、增长驱动因素和挑战，以及涵盖约 25 家多柔比星市场供应商的供应商分析。

我们提供对当前市场情况、最新趋势和驱动因素以及整体市场环境的最新分析。 市场受到癌症患者患病率增加、产品发布增加和诊断方法进步的推动。

该研究指出，在癌症中引入精准癌症医学是未来几年推动多柔比星市场增长的主要原因之一。 此外，增加创新生物製剂的研究和开发以及供应商增加无机增长战略预计将导致巨大的市场需求。

内容

第 1 章执行摘要

• 市场概览

第二章市场状况

• 市场生态系统

第三章市场规模

• 市场定义
• 市场分析
• 2022 年市场规模
• 2022-2027 年市场展望

第 4 章市场规模结果

• 阿霉素全球市场 2017-2021
• 2017-2021 年药品细分市场分析
• 2017-2021 年最终用户细分分析
• 2017-2021 年各地区分析
• 2017-2021 年国家/地区分析

第五章五力分析

• 五力总结
• 买家的议价能力
• 供应商的议价能力
• 新进入者的威胁
• 替代品的威胁
• 竞争威胁
• 市场

第 6 章按配方进行市场细分

• 市场细分
• 通过比较公式
• 冻干粉：2022-2027 年市场规模和预测
• 阿霉素注射液：2022-2027 年市场规模和预测
• 按配方划分的市场机会

第 7 章市场细分：按最终用户

• 市场细分
• 比较：按最终用户
• 医院药房：2022-2027 年市场规模和预测
• 零售药店：2022-2027 年市场规模和预测
• 在线药店：2022 年至 2027 年的市场规模和预测
• 其他：2022-2027 年市场规模和预测
• 市场机会：最终用户

第八章客户情况

• 客户情况总结

第九章区域情况

• 区域细分
• 按地区比较
• 北美：2022-2027 年市场规模和预测
• 欧洲：2022-2027 年市场规模和预测
• 亚洲：2022-2027 年市场规模和预测
• 世界其他地区：2022-2027 年市场规模和预测
• 美国：2022-2027 年市场规模和预测
• 德国：2022-2027 年市场规模和预测
• 中国：2022-2027 年市场规模和预测
• 英国：2022-2027 年市场规模和预测
• 加拿大：2022-2027 年市场规模和预测
• 市场机会：按地区

第 10 章驱动因素、挑战和趋势

• 市场驱动力
• 市场挑战
• 挑战的驱动因素和影响
• 市场趋势

第 11 章供应商概况

• 概览
• 供应商情况
• 混乱情况
• 行业风险

第 12 章供应商分析

• 目标供应商
• 供应商市场定位
• Baxter International Inc.
• Cipla Ltd.
• Dr Reddys Laboratories Ltd.
• Hikma Pharmaceuticals Plc
• Intas Pharmaceuticals Ltd.
• Johnson and Johnson
• Meiji Holdings Co. Ltd.
• Merck KGaA
• Novartis AG
• Pfizer Inc.
• S. G. Biopharm Pvt. Ltd.
• Sun Pharmaceutical Industries Ltd.
• Synbias Pharma AG
• Teva Pharmaceutical Industries Ltd.
• Zydus Lifesciences Ltd.

第13章 附录

Technavio has been monitoring the doxorubicin market and is forecast to grow by $469.97 mn during 2022-2027, accelerating at a CAGR of 6.07% during the forecast period. Our report on the doxorubicin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of cancer cases, increasing product launches, and advancements in diagnostic methods.

Technavio's doxorubicin market is segmented as below:

By Formulation

• Lyophilized powder
• Doxorubicin injection

By End-user

• Hospital pharmacy
• Retail pharmacy
• Online pharmacy
• Others

By Geography

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the introduction of precision cancer medicine in cancer as one of the prime reasons driving the doxorubicin market growth during the next few years. Also, increase in R&D of innovative biologics and increasing inorganic growth strategies by the vendors will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the doxorubicin market covers the following areas:

• Doxorubicin market sizing
• Doxorubicin market forecast
• Doxorubicin market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading doxorubicin market vendors that include Aurobindo Pharma Ltd., Baxter International Inc., Cipla Ltd., Dr Reddys Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson, Meiji Holdings Co. Ltd., Merck KGaA, Mitsui and Co. Ltd., Novartis AG, Pfizer Inc., Pharmagen CZ s.r.o, Sun Pharmaceutical Industries Ltd., Synbias Pharma AG, TTY Biopharm Co. Ltd., Zydus Lifesciences Ltd., S. G. Biopharm Pvt. Ltd., and Teva Pharmaceutical Industries Ltd. Also, the doxorubicin market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market by Geography
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Formulation
• Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global doxorubicin market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on Global doxorubicin market 2017 - 2021 ($ million)
• 4.2 Formulation Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Formulation Segment 2017 - 2021 ($ million)
• 4.3 End-user Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Formulation

• 6.1 Market segments
• Exhibit 30: Chart on Formulation - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Formulation - Market share 2022-2027 (%)
• 6.2 Comparison by Formulation
• Exhibit 32: Chart on Comparison by Formulation
• Exhibit 33: Data Table on Comparison by Formulation
• 6.3 Lyophilized powder - Market size and forecast 2022-2027
• Exhibit 34: Chart on Lyophilized powder - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Lyophilized powder - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Lyophilized powder - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Lyophilized powder - Year-over-year growth 2022-2027 (%)
• 6.4 Doxorubicin injection - Market size and forecast 2022-2027
• Exhibit 38: Chart on Doxorubicin injection - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Doxorubicin injection - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Doxorubicin injection - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Doxorubicin injection - Year-over-year growth 2022-2027 (%)
• 6.5 Market opportunity by Formulation
• Exhibit 42: Market opportunity by Formulation ($ million)
• Exhibit 43: Data Table on Market opportunity by Formulation ($ million)

7 Market Segmentation by End-user

• 7.1 Market segments
• Exhibit 44: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 45: Data Table on End-user - Market share 2022-2027 (%)
• 7.2 Comparison by End-user
• Exhibit 46: Chart on Comparison by End-user
• Exhibit 47: Data Table on Comparison by End-user
• 7.3 Hospital pharmacy - Market size and forecast 2022-2027
• Exhibit 48: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 50: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibit 51: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
• 7.4 Retail pharmacy - Market size and forecast 2022-2027
• Exhibit 52: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
• 7.5 Online pharmacy - Market size and forecast 2022-2027
• Exhibit 56: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
• 7.6 Others - Market size and forecast 2022-2027
• Exhibit 60: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Others - Year-over-year growth 2022-2027 (%)
• 7.7 Market opportunity by End-user
• Exhibit 64: Market opportunity by End-user ($ million)
• Exhibit 65: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 67: Chart on Market share by geography 2022-2027 (%)
• Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 69: Chart on Geographic comparison
• Exhibit 70: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 Germany - Market size and forecast 2022-2027
• Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.9 China - Market size and forecast 2022-2027
• Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.10 UK - Market size and forecast 2022-2027
• Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.11 Canada - Market size and forecast 2022-2027
• Exhibit 103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity by geography
• Exhibit 107: Market opportunity by geography ($ million)
• Exhibit 108: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 109: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 111: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 112: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 113: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 114: Matrix on vendor position and classification
• 12.3 Baxter International Inc.
• Exhibit 115: Baxter International Inc. - Overview
• Exhibit 116: Baxter International Inc. - Business segments
• Exhibit 117: Baxter International Inc. - Key news
• Exhibit 118: Baxter International Inc. - Key offerings
• Exhibit 119: Baxter International Inc. - Segment focus
• 12.4 Cipla Ltd.
• Exhibit 120: Cipla Ltd. - Overview
• Exhibit 121: Cipla Ltd. - Business segments
• Exhibit 122: Cipla Ltd. - Key news
• Exhibit 123: Cipla Ltd. - Key offerings
• Exhibit 124: Cipla Ltd. - Segment focus
• 12.5 Dr Reddys Laboratories Ltd.
• Exhibit 125: Dr Reddys Laboratories Ltd. - Overview
• Exhibit 126: Dr Reddys Laboratories Ltd. - Business segments
• Exhibit 127: Dr Reddys Laboratories Ltd. - Key offerings
• Exhibit 128: Dr Reddys Laboratories Ltd. - Segment focus
• 12.6 Hikma Pharmaceuticals Plc
• Exhibit 129: Hikma Pharmaceuticals Plc - Overview
• Exhibit 130: Hikma Pharmaceuticals Plc - Business segments
• Exhibit 131: Hikma Pharmaceuticals Plc - Key offerings
• Exhibit 132: Hikma Pharmaceuticals Plc - Segment focus
• 12.7 Intas Pharmaceuticals Ltd.
• Exhibit 133: Intas Pharmaceuticals Ltd. - Overview
• Exhibit 134: Intas Pharmaceuticals Ltd. - Product / Service
• Exhibit 135: Intas Pharmaceuticals Ltd. - Key offerings
• 12.8 Johnson and Johnson
• Exhibit 136: Johnson and Johnson - Overview
• Exhibit 137: Johnson and Johnson - Business segments
• Exhibit 138: Johnson and Johnson - Key news
• Exhibit 139: Johnson and Johnson - Key offerings
• Exhibit 140: Johnson and Johnson - Segment focus
• 12.9 Meiji Holdings Co. Ltd.
• Exhibit 141: Meiji Holdings Co. Ltd. - Overview
• Exhibit 142: Meiji Holdings Co. Ltd. - Business segments
• Exhibit 143: Meiji Holdings Co. Ltd. - Key news
• Exhibit 144: Meiji Holdings Co. Ltd. - Key offerings
• Exhibit 145: Meiji Holdings Co. Ltd. - Segment focus
• 12.10 Merck KGaA
• Exhibit 146: Merck KGaA - Overview
• Exhibit 147: Merck KGaA - Business segments
• Exhibit 148: Merck KGaA - Key news
• Exhibit 149: Merck KGaA - Key offerings
• Exhibit 150: Merck KGaA - Segment focus
• 12.11 Novartis AG
• Exhibit 151: Novartis AG - Overview
• Exhibit 152: Novartis AG - Business segments
• Exhibit 153: Novartis AG - Key offerings
• Exhibit 154: Novartis AG - Segment focus
• 12.12 Pfizer Inc.
• Exhibit 155: Pfizer Inc. - Overview
• Exhibit 156: Pfizer Inc. - Product / Service
• Exhibit 157: Pfizer Inc. - Key news
• Exhibit 158: Pfizer Inc. - Key offerings
• 12.13 S. G. Biopharm Pvt. Ltd.
• Exhibit 159: S. G. Biopharm Pvt. Ltd. - Overview
• Exhibit 160: S. G. Biopharm Pvt. Ltd. - Product / Service
• Exhibit 161: S. G. Biopharm Pvt. Ltd. - Key offerings
• 12.14 Sun Pharmaceutical Industries Ltd.
• Exhibit 162: Sun Pharmaceutical Industries Ltd. - Overview
• Exhibit 163: Sun Pharmaceutical Industries Ltd. - Product / Service
• Exhibit 164: Sun Pharmaceutical Industries Ltd. - Key offerings
• 12.15 Synbias Pharma AG
• Exhibit 165: Synbias Pharma AG - Overview
• Exhibit 166: Synbias Pharma AG - Product / Service
• Exhibit 167: Synbias Pharma AG - Key offerings
• 12.16 Teva Pharmaceutical Industries Ltd.
• Exhibit 168: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 169: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 170: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 171: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 172: Teva Pharmaceutical Industries Ltd. - Segment focus
• 12.17 Zydus Lifesciences Ltd.
• Exhibit 173: Zydus Lifesciences Ltd. - Overview
• Exhibit 174: Zydus Lifesciences Ltd. - Business segments
• Exhibit 175: Zydus Lifesciences Ltd. - Key offerings
• Exhibit 176: Zydus Lifesciences Ltd. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 177: Inclusions checklist
• Exhibit 178: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 179: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 180: Research methodology
• Exhibit 181: Validation techniques employed for market sizing
• Exhibit 182: Information sources
• 13.5 List of abbreviations
• Exhibit 183: List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market by Geography
• Exhibits5: Executive Summary - Chart on Market Segmentation by Formulation
• Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on Global doxorubicin market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - Formulation Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Formulation - Market share 2022-2027 (%)
• Exhibits31: Data Table on Formulation - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Formulation
• Exhibits33: Data Table on Comparison by Formulation
• Exhibits34: Chart on Lyophilized powder - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Lyophilized powder - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Lyophilized powder - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Lyophilized powder - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Doxorubicin injection - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on Doxorubicin injection - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on Doxorubicin injection - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Doxorubicin injection - Year-over-year growth 2022-2027 (%)
• Exhibits42: Market opportunity by Formulation ($ million)
• Exhibits43: Data Table on Market opportunity by Formulation ($ million)
• Exhibits44: Chart on End-user - Market share 2022-2027 (%)
• Exhibits45: Data Table on End-user - Market share 2022-2027 (%)
• Exhibits46: Chart on Comparison by End-user
• Exhibits47: Data Table on Comparison by End-user
• Exhibits48: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibits49: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibits50: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibits51: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibits52: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibits53: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibits54: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibits55: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibits56: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibits57: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibits58: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibits59: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibits60: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits62: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibits63: Data Table on Others - Year-over-year growth 2022-2027 (%)
• Exhibits64: Market opportunity by End-user ($ million)
• Exhibits65: Data Table on Market opportunity by End-user ($ million)
• Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits67: Chart on Market share by geography 2022-2027 (%)
• Exhibits68: Data Table on Market share by geography 2022-2027 (%)
• Exhibits69: Chart on Geographic comparison
• Exhibits70: Data Table on Geographic comparison
• Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits95: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibits96: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibits97: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits98: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits99: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits100: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits101: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits102: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits105: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits107: Market opportunity by geography ($ million)
• Exhibits108: Data Tables on Market opportunity by geography ($ million)
• Exhibits109: Impact of drivers and challenges in 2022 and 2027
• Exhibits110: Overview on Criticality of inputs and Factors of differentiation
• Exhibits111: Overview on factors of disruption
• Exhibits112: Impact of key risks on business
• Exhibits113: Vendors covered
• Exhibits114: Matrix on vendor position and classification
• Exhibits115: Baxter International Inc. - Overview
• Exhibits116: Baxter International Inc. - Business segments
• Exhibits117: Baxter International Inc. - Key news
• Exhibits118: Baxter International Inc. - Key offerings
• Exhibits119: Baxter International Inc. - Segment focus
• Exhibits120: Cipla Ltd. - Overview
• Exhibits121: Cipla Ltd. - Business segments
• Exhibits122: Cipla Ltd. - Key news
• Exhibits123: Cipla Ltd. - Key offerings
• Exhibits124: Cipla Ltd. - Segment focus
• Exhibits125: Dr Reddys Laboratories Ltd. - Overview
• Exhibits126: Dr Reddys Laboratories Ltd. - Business segments
• Exhibits127: Dr Reddys Laboratories Ltd. - Key offerings
• Exhibits128: Dr Reddys Laboratories Ltd. - Segment focus
• Exhibits129: Hikma Pharmaceuticals Plc - Overview
• Exhibits130: Hikma Pharmaceuticals Plc - Business segments
• Exhibits131: Hikma Pharmaceuticals Plc - Key offerings
• Exhibits132: Hikma Pharmaceuticals Plc - Segment focus
• Exhibits133: Intas Pharmaceuticals Ltd. - Overview
• Exhibits134: Intas Pharmaceuticals Ltd. - Product / Service
• Exhibits135: Intas Pharmaceuticals Ltd. - Key offerings
• Exhibits136: Johnson and Johnson - Overview
• Exhibits137: Johnson and Johnson - Business segments
• Exhibits138: Johnson and Johnson - Key news
• Exhibits139: Johnson and Johnson - Key offerings
• Exhibits140: Johnson and Johnson - Segment focus
• Exhibits141: Meiji Holdings Co. Ltd. - Overview
• Exhibits142: Meiji Holdings Co. Ltd. - Business segments
• Exhibits143: Meiji Holdings Co. Ltd. - Key news
• Exhibits144: Meiji Holdings Co. Ltd. - Key offerings
• Exhibits145: Meiji Holdings Co. Ltd. - Segment focus
• Exhibits146: Merck KGaA - Overview
• Exhibits147: Merck KGaA - Business segments
• Exhibits148: Merck KGaA - Key news
• Exhibits149: Merck KGaA - Key offerings
• Exhibits150: Merck KGaA - Segment focus
• Exhibits151: Novartis AG - Overview
• Exhibits152: Novartis AG - Business segments
• Exhibits153: Novartis AG - Key offerings
• Exhibits154: Novartis AG - Segment focus
• Exhibits155: Pfizer Inc. - Overview
• Exhibits156: Pfizer Inc. - Product / Service
• Exhibits157: Pfizer Inc. - Key news
• Exhibits158: Pfizer Inc. - Key offerings
• Exhibits159: S. G. Biopharm Pvt. Ltd. - Overview
• Exhibits160: S. G. Biopharm Pvt. Ltd. - Product / Service
• Exhibits161: S. G. Biopharm Pvt. Ltd. - Key offerings
• Exhibits162: Sun Pharmaceutical Industries Ltd. - Overview
• Exhibits163: Sun Pharmaceutical Industries Ltd. - Product / Service
• Exhibits164: Sun Pharmaceutical Industries Ltd. - Key offerings
• Exhibits165: Synbias Pharma AG - Overview
• Exhibits166: Synbias Pharma AG - Product / Service
• Exhibits167: Synbias Pharma AG - Key offerings
• Exhibits168: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits169: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits170: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits171: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits172: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits173: Zydus Lifesciences Ltd. - Overview
• Exhibits174: Zydus Lifesciences Ltd. - Business segments
• Exhibits175: Zydus Lifesciences Ltd. - Key offerings
• Exhibits176: Zydus Lifesciences Ltd. - Segment focus
• Exhibits177: Inclusions checklist
• Exhibits178: Exclusions checklist
• Exhibits179: Currency conversion rates for US$
• Exhibits180: Research methodology
• Exhibits181: Validation techniques employed for market sizing
• Exhibits182: Information sources
• Exhibits183: List of abbreviations